Clinical Trial Update: Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer [Phase 1, Phase 2]

View source ↗

Summary

Pfizer is conducting a Phase 1/2 study of PF-08634404 in adults with locally advanced or metastatic renal cell carcinoma; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• PF-08634404

Snippet

Sponsor: Pfizer | Conditions: Carcinoma, Renal Cell, Advanced Renal Cell Carcinoma | Phase 1, Phase 2 | Status: RECRUITING